Craig Anderson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Craig Anderson has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Duncan Lee
School of Mathematics and Statistics, University of Glasgow
5 shared publications - Louise Ryan
School of Mathematical and Physical Sciences, University of Technology Sydney, Ultimo, Australia
4 shared publications Nema Dean
School of Mathematics and Statistics, University of Glasgow, University Gardens, Glasgow, G12 8QW, Scotland
3 shared publications- Hamidul Huque
University of New South Wales
2 shared publications Alessandro Gasparini
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
1 shared publicationAlex McConnachie
Robertson Centre for Biostatistics, Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK
1 shared publication
Latest Publications
- Open Access
- 19 December 2023
- Published by Elsevier in The American Journal of Clinical Nutrition
- Vol. 119 (2) , 444-455
Postnatal growth in small vulnerable newborns: a longitudinal study of 2 million Brazilians using routine register-based linked data
- 19 December 2023
- Published by Elsevier in The American Journal of Clinical Nutrition
- Vol. 119 (2) , 444-455
Open AccessPostnatal growth in small vulnerable newborns: a longitudinal study of 2 million Brazilians using routine register-based linked data
- Open Access
- 1 November 2022
- Published by Springer Nature in BMC Medicine
- Vol. 20 (1) , 1-13
The presence and impact of multimorbidity clusters on adverse outcomes across the spectrum of kidney function
Background: Multimorbidity (the presence of two or more chronic conditions) is common amongst people with chronic kidney disease, but it is unclear which conditions cluster together and if this changes as kidney function declines. We explored which clusters of conditions are associated with different estimated glomerular filtration rates (eGFRs) and studied associations between these clusters and adverse outcomes. Methods: Two population-based cohort studies were used: the Stockholm Creatinine Measurements project (SCREAM, Sweden, 2006–2018) and the Secure Anonymised Information Linkage Databank (SAIL, Wales, 2006–2021). We studied participants in SCREAM (404,681 adults) and SAIL (533,362) whose eGFR declined lower than thresholds (90, 75, 60, 45, 30 and 15 mL/min/1.73m2). Clusters based on 27 chronic conditions were identified. We described the most common chronic condition(s) in each cluster and studied their association with adverse outcomes using Cox proportional hazards models (all-cause mortality (ACM) and major adverse cardiovascular events (MACE)). Results: Chronic conditions became more common and clustered differently across lower eGFR categories. At eGFR 90, 75, and 60 mL/min/1.73m2, most participants were in large clusters with no prominent conditions. At eGFR 15 and 30 mL/min/1.73m2, clusters involving cardiovascular conditions were larger and were at the highest risk of adverse outcomes. At eGFR 30 mL/min/1.73m2, in the heart failure, peripheral vascular disease and diabetes cluster in SCREAM, ACM hazard ratio (HR) is 2.66 (95% confidence interval (CI) 2.31–3.07) and MACE HR is 4.18 (CI 3.65–4.78); in the heart failure and atrial fibrillation cluster in SAIL, ACM HR is 2.23 (CI 2.04 to 2.44) and MACE HR is 3.43 (CI 3.22–3.64). Chronic pain and depression were common and associated with adverse outcomes when combined with physical conditions. At eGFR 30 mL/min/1.73m2, in the chronic pain, heart failure and myocardial infarction cluster in SCREAM, ACM HR is 2.00 (CI 1.62–2.46) and MACE HR is 4.09 (CI 3.39–4.93); in the depression, chronic pain and stroke cluster in SAIL, ACM HR is 1.38 (CI 1.18–1.61) and MACE HR is 1.58 (CI 1.42–1.76). Conclusions: Patterns of multimorbidity and corresponding risk of adverse outcomes varied with declining eGFR. While diabetes and cardiovascular disease are known high-risk conditions, chronic pain and depression emerged as important conditions and associated with adverse outcomes when combined with physical conditions.
- 1 November 2022
- Published by Springer Nature in BMC Medicine
- Vol. 20 (1) , 1-13
Open AccessThe presence and impact of multimorbidity clusters on adverse outcomes across the spectrum of kidney function
Background: Multimorbidity (the presence of two or more chronic conditions) is common amongst people with chronic kidney disease, but it is unclear which conditions cluster together and if this changes as kidney function declines. We explored which clusters of conditions are associated with different estimated glomerular filtration rates (eGFRs) and studied associations between these clusters and adverse outcomes. Methods: Two population-based cohort studies were used: the Stockholm Creatinine Measurements project (SCREAM, Sweden, 2006–2018) and the Secure Anonymised Information Linkage Databank (SAIL, Wales, 2006–2021). We studied participants in SCREAM (404,681 adults) and SAIL (533,362) whose eGFR declined lower than thresholds (90, 75, 60, 45, 30 and 15 mL/min/1.73m2). Clusters based on 27 chronic conditions were identified. We described the most common chronic condition(s) in each cluster and studied their association with adverse outcomes using Cox proportional hazards models (all-cause mortality (ACM) and major adverse cardiovascular events (MACE)). Results: Chronic conditions became more common and clustered differently across lower eGFR categories. At eGFR 90, 75, and 60 mL/min/1.73m2, most participants were in large clusters with no prominent conditions. At eGFR 15 and 30 mL/min/1.73m2, clusters involving cardiovascular conditions were larger and were at the highest risk of adverse outcomes. At eGFR 30 mL/min/1.73m2, in the heart failure, peripheral vascular disease and diabetes cluster in SCREAM, ACM hazard ratio (HR) is 2.66 (95% confidence interval (CI) 2.31–3.07) and MACE HR is 4.18 (CI 3.65–4.78); in the heart failure and atrial fibrillation cluster in SAIL, ACM HR is 2.23 (CI 2.04 to 2.44) and MACE HR is 3.43 (CI 3.22–3.64). Chronic pain and depression were common and associated with adverse outcomes when combined with physical conditions. At eGFR 30 mL/min/1.73m2, in the chronic pain, heart failure and myocardial infarction cluster in SCREAM, ACM HR is 2.00 (CI 1.62–2.46) and MACE HR is 4.09 (CI 3.39–4.93); in the depression, chronic pain and stroke cluster in SAIL, ACM HR is 1.38 (CI 1.18–1.61) and MACE HR is 1.58 (CI 1.42–1.76). Conclusions: Patterns of multimorbidity and corresponding risk of adverse outcomes varied with declining eGFR. While diabetes and cardiovascular disease are known high-risk conditions, chronic pain and depression emerged as important conditions and associated with adverse outcomes when combined with physical conditions.
- Open Access
- 16 August 2022
- Published by Oxford University Press (OUP) in Biometrics
- Vol. 79 (3) , 2691-2704
Delivering Spatially Comparable Inference on the Risks of Multiple Severities of Respiratory Disease from Spatially Misaligned Disease Count Data
Population-level disease risk varies between communities, and public health professionals are interested in mapping this spatial variation to monitor the locations of high-risk areas and the magnitudes of health inequalities. Almost all of these risk maps relate to a single severity of disease outcome, such as hospitalization, which thus ignores any cases of disease of a different severity, such as a mild case treated in a primary care setting. These spatially-varying risk maps are estimated from spatially aggregated disease count data, but the set of areal units to which these disease counts relate often varies by severity. Thus, the statistical challenge is to provide spatially comparable inference from multiple sets of spatially misaligned disease count data, and an additional complexity is that the spatial extents of the areal units for some severities are partially unknown. This paper thus proposes a novel spatial realignment approach for multivariate misaligned count data, and applies it to the first study delivering spatially comparable inference for multiple severities of the same disease. Inference is via a novel spatially smoothed data augmented MCMC algorithm, and the methods are motivated by a new study of respiratory disease risk in Scotland in 2017.
- 16 August 2022
- Published by Oxford University Press (OUP) in Biometrics
- Vol. 79 (3) , 2691-2704
Open AccessDelivering Spatially Comparable Inference on the Risks of Multiple Severities of Respiratory Disease from Spatially Misaligned Disease Count Data
Population-level disease risk varies between communities, and public health professionals are interested in mapping this spatial variation to monitor the locations of high-risk areas and the magnitudes of health inequalities. Almost all of these risk maps relate to a single severity of disease outcome, such as hospitalization, which thus ignores any cases of disease of a different severity, such as a mild case treated in a primary care setting. These spatially-varying risk maps are estimated from spatially aggregated disease count data, but the set of areal units to which these disease counts relate often varies by severity. Thus, the statistical challenge is to provide spatially comparable inference from multiple sets of spatially misaligned disease count data, and an additional complexity is that the spatial extents of the areal units for some severities are partially unknown. This paper thus proposes a novel spatial realignment approach for multivariate misaligned count data, and applies it to the first study delivering spatially comparable inference for multiple severities of the same disease. Inference is via a novel spatially smoothed data augmented MCMC algorithm, and the methods are motivated by a new study of respiratory disease risk in Scotland in 2017.
- Open Access
- 14 March 2022
- Published by SAGE Publications in Statistical Methods in Medical Research
- Vol. 31 (6) , 1184-1203
Spatio-temporal disease risk estimation using clustering-based adjacency modelling
Conditional autoregressive models are typically used to capture the spatial autocorrelation present in areal unit disease count data when estimating the spatial pattern in disease risk. This correlation is represented by a binary neighbourhood matrix based on a border sharing specification, which enforces spatial correlation between geographically neighbouring areas. However, enforcing such correlation will mask any discontinuities in the disease risk surface, thus impeding the detection of clusters of areas that exhibit higher or lower risks compared to their neighbours. Here we propose novel methodology to account for these clusters and discontinuities in disease risk via a two-stage modelling approach, which either forces the clusters/discontinuities to be the same for all time periods or allows them to evolve dynamically over time. Stage one constructs a set of candidate neighbourhood matrices to represent a range of possible cluster/discontinuity structures in the data, and stage two estimates an appropriate structure(s) by treating the neighbourhood matrix as an additional parameter to estimate within a Bayesian spatio-temporal disease mapping model. The effectiveness of our novel methodology is evidenced by simulation, before being applied to a new study of respiratory disease risk in Greater Glasgow, Scotland from 2011 to 2017.
- 14 March 2022
- Published by SAGE Publications in Statistical Methods in Medical Research
- Vol. 31 (6) , 1184-1203
Open AccessSpatio-temporal disease risk estimation using clustering-based adjacency modelling
Conditional autoregressive models are typically used to capture the spatial autocorrelation present in areal unit disease count data when estimating the spatial pattern in disease risk. This correlation is represented by a binary neighbourhood matrix based on a border sharing specification, which enforces spatial correlation between geographically neighbouring areas. However, enforcing such correlation will mask any discontinuities in the disease risk surface, thus impeding the detection of clusters of areas that exhibit higher or lower risks compared to their neighbours. Here we propose novel methodology to account for these clusters and discontinuities in disease risk via a two-stage modelling approach, which either forces the clusters/discontinuities to be the same for all time periods or allows them to evolve dynamically over time. Stage one constructs a set of candidate neighbourhood matrices to represent a range of possible cluster/discontinuity structures in the data, and stage two estimates an appropriate structure(s) by treating the neighbourhood matrix as an additional parameter to estimate within a Bayesian spatio-temporal disease mapping model. The effectiveness of our novel methodology is evidenced by simulation, before being applied to a new study of respiratory disease risk in Greater Glasgow, Scotland from 2011 to 2017.
- 12 July 2019
- Published by Wiley in Statistics in Medicine
- Vol. 38 (19) , 3584-3585
Response to Professor Tim Cole's commentary: Methods for calculating growth trajectories and constructing growth centiles
- 12 July 2019
- Published by Wiley in Statistics in Medicine
- Vol. 38 (19) , 3584-3585
Response to Professor Tim Cole's commentary: Methods for calculating growth trajectories and constructing growth centiles
- Open Access
- 9 August 2018
- Published by Wiley in Statistics in Medicine
- Vol. 38 (19) , 3555-3570
Comparing predictive abilities of longitudinal child growth models
The Bill and Melinda Gates Foundation's Healthy Birth, Growth and Development knowledge integration project aims to improve the overall health and well‐being of children across the world. The project aims to integrate information from multiple child growth studies to allow health professionals and policy makers to make informed decisions about interventions in lower and middle income countries. To achieve this goal, we must first understand the conditions that impact on the growth and development of children, and this requires sensible models for characterising different growth patterns. The contribution of this paper is to provide a quantitative comparison of the predictive abilities of various statistical growth modelling techniques based on a novel leave‐one‐out validation approach. The majority of existing studies have used raw growth data for modelling, but we show that fitting models to standardised data provide more accurate estimation and prediction. Our work is illustrated with an example from a study into child development in a middle income country in South America.
- 9 August 2018
- Published by Wiley in Statistics in Medicine
- Vol. 38 (19) , 3555-3570
Open AccessComparing predictive abilities of longitudinal child growth models
The Bill and Melinda Gates Foundation's Healthy Birth, Growth and Development knowledge integration project aims to improve the overall health and well‐being of children across the world. The project aims to integrate information from multiple child growth studies to allow health professionals and policy makers to make informed decisions about interventions in lower and middle income countries. To achieve this goal, we must first understand the conditions that impact on the growth and development of children, and this requires sensible models for characterising different growth patterns. The contribution of this paper is to provide a quantitative comparison of the predictive abilities of various statistical growth modelling techniques based on a novel leave‐one‐out validation approach. The majority of existing studies have used raw growth data for modelling, but we show that fitting models to standardised data provide more accurate estimation and prediction. Our work is illustrated with an example from a study into child development in a middle income country in South America.
- Open Access
- 26 April 2018
- Published by Wiley in Statistics in Medicine
- Vol. 38 (19) , 3540-3554
Using data from multiple studies to develop a child growth correlation matrix
In many countries, the monitoring of child growth does not occur in a regular manner, and instead, we may have to rely on sporadic observations that are subject to substantial measurement error. In these countries, it can be difficult to identify patterns of poor growth, and faltering children may miss out on essential health interventions. The contribution of this paper is to provide a framework for pooling together multiple datasets, thus allowing us to overcome the issue of sparse data and provide improved estimates of growth. We use data from multiple longitudinal growth studies to construct a common correlation matrix that can be used in estimation and prediction of child growth. We propose a novel 2‐stage approach: In stage 1, we construct a raw matrix via a set of univariate meta‐analyses, and in stage 2, we smooth this raw matrix to obtain a more realistic correlation matrix. The methodology is illustrated using data from 16 child growth studies from the Bill and Melinda Gates Foundation's Healthy Birth Growth and Development knowledge integration project and identifies strong correlation for both height and weight between the ages of 4 and 12 years. We use a case study to provide an example of how this matrix can be used to help compute growth measures.
- 26 April 2018
- Published by Wiley in Statistics in Medicine
- Vol. 38 (19) , 3540-3554
Open AccessUsing data from multiple studies to develop a child growth correlation matrix
In many countries, the monitoring of child growth does not occur in a regular manner, and instead, we may have to rely on sporadic observations that are subject to substantial measurement error. In these countries, it can be difficult to identify patterns of poor growth, and faltering children may miss out on essential health interventions. The contribution of this paper is to provide a framework for pooling together multiple datasets, thus allowing us to overcome the issue of sparse data and provide improved estimates of growth. We use data from multiple longitudinal growth studies to construct a common correlation matrix that can be used in estimation and prediction of child growth. We propose a novel 2‐stage approach: In stage 1, we construct a raw matrix via a set of univariate meta‐analyses, and in stage 2, we smooth this raw matrix to obtain a more realistic correlation matrix. The methodology is illustrated using data from 16 child growth studies from the Bill and Melinda Gates Foundation's Healthy Birth Growth and Development knowledge integration project and identifies strong correlation for both height and weight between the ages of 4 and 12 years. We use a case study to provide an example of how this matrix can be used to help compute growth measures.
- 25 March 2018
- Published by Wiley in Biometrical Journal
- Vol. 60 (3) , 597-615
Smooth individual level covariates adjustment in disease mapping
Spatial models for disease mapping should ideally account for covariates measured both at individual and area levels. The newly available “indiCAR” model fits the popular conditional autoregresssive (CAR) model by accommodating both individual and group level covariates while adjusting for spatial correlation in the disease rates. This algorithm has been shown to be effective but assumes log‐linear associations between individual level covariates and outcome. In many studies, the relationship between individual level covariates and the outcome may be non‐log‐linear, and methods to track such nonlinearity between individual level covariate and outcome in spatial regression modeling are not well developed. In this paper, we propose a new algorithm, smooth‐indiCAR, to fit an extension to the popular conditional autoregresssive model that can accommodate both linear and nonlinear individual level covariate effects while adjusting for group level covariates and spatial correlation in the disease rates. In this formulation, the effect of a continuous individual level covariate is accommodated via penalized splines. We describe a two‐step estimation procedure to obtain reliable estimates of individual and group level covariate effects where both individual and group level covariate effects are estimated separately. This distributed computing framework enhances its application in the Big Data domain with a large number of individual/group level covariates. We evaluate the performance of smooth‐indiCAR through simulation. Our results indicate that the smooth‐indiCAR method provides reliable estimates of all regression and random effect parameters. We illustrate our proposed methodology with an analysis of data on neutropenia admissions in New South Wales (NSW), Australia.
- 25 March 2018
- Published by Wiley in Biometrical Journal
- Vol. 60 (3) , 597-615
Smooth individual level covariates adjustment in disease mapping
Spatial models for disease mapping should ideally account for covariates measured both at individual and area levels. The newly available “indiCAR” model fits the popular conditional autoregresssive (CAR) model by accommodating both individual and group level covariates while adjusting for spatial correlation in the disease rates. This algorithm has been shown to be effective but assumes log‐linear associations between individual level covariates and outcome. In many studies, the relationship between individual level covariates and the outcome may be non‐log‐linear, and methods to track such nonlinearity between individual level covariate and outcome in spatial regression modeling are not well developed. In this paper, we propose a new algorithm, smooth‐indiCAR, to fit an extension to the popular conditional autoregresssive model that can accommodate both linear and nonlinear individual level covariate effects while adjusting for group level covariates and spatial correlation in the disease rates. In this formulation, the effect of a continuous individual level covariate is accommodated via penalized splines. We describe a two‐step estimation procedure to obtain reliable estimates of individual and group level covariate effects where both individual and group level covariate effects are estimated separately. This distributed computing framework enhances its application in the Big Data domain with a large number of individual/group level covariates. We evaluate the performance of smooth‐indiCAR through simulation. Our results indicate that the smooth‐indiCAR method provides reliable estimates of all regression and random effect parameters. We illustrate our proposed methodology with an analysis of data on neutropenia admissions in New South Wales (NSW), Australia.
- Open Access
- 3 February 2017
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 14 (2) , 146
A Comparison of Spatio-Temporal Disease Mapping Approaches Including an Application to Ischaemic Heart Disease in New South Wales, Australia
The field of spatio-temporal modelling has witnessed a recent surge as a result of developments in computational power and increased data collection. These developments allow analysts to model the evolution of health outcomes in both space and time simultaneously. This paper models the trends in ischaemic heart disease (IHD) in New South Wales, Australia over an eight-year period between 2006 and 2013. A number of spatio-temporal models are considered, and we propose a novel method for determining the goodness-of-fit for these models by outlining a spatio-temporal extension of the Moran’s I statistic. We identify an overall decrease in the rates of IHD, but note that the extent of this health improvement varies across the state. In particular, we identified a number of remote areas in the north and west of the state where the risk stayed constant or even increased slightly.
- 3 February 2017
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 14 (2) , 146
Open AccessA Comparison of Spatio-Temporal Disease Mapping Approaches Including an Application to Ischaemic Heart Disease in New South Wales, Australia
The field of spatio-temporal modelling has witnessed a recent surge as a result of developments in computational power and increased data collection. These developments allow analysts to model the evolution of health outcomes in both space and time simultaneously. This paper models the trends in ischaemic heart disease (IHD) in New South Wales, Australia over an eight-year period between 2006 and 2013. A number of spatio-temporal models are considered, and we propose a novel method for determining the goodness-of-fit for these models by outlining a spatio-temporal extension of the Moran’s I statistic. We identify an overall decrease in the rates of IHD, but note that the extent of this health improvement varies across the state. In particular, we identified a number of remote areas in the north and west of the state where the risk stayed constant or even increased slightly.
- 5 August 2016
- Published by Wiley in Biometrical Journal
- Vol. 59 (1) , 41-56
Spatial clustering of average risks and risk trends in Bayesian disease mapping
Spatiotemporal disease mapping focuses on estimating the spatial pattern in disease risk across a set of nonoverlapping areal units over a fixed period of time. The key aim of such research is to identify areas that have a high average level of disease risk or where disease risk is increasing over time, thus allowing public health interventions to be focused on these areas. Such aims are well suited to the statistical approach of clustering, and while much research has been done in this area in a purely spatial setting, only a handful of approaches have focused on spatiotemporal clustering of disease risk. Therefore, this paper outlines a new modeling approach for clustering spatiotemporal disease risk data, by clustering areas based on both their mean risk levels and the behavior of their temporal trends. The efficacy of the methodology is established by a simulation study, and is illustrated by a study of respiratory disease risk in Glasgow, Scotland.
- 5 August 2016
- Published by Wiley in Biometrical Journal
- Vol. 59 (1) , 41-56
Spatial clustering of average risks and risk trends in Bayesian disease mapping
Spatiotemporal disease mapping focuses on estimating the spatial pattern in disease risk across a set of nonoverlapping areal units over a fixed period of time. The key aim of such research is to identify areas that have a high average level of disease risk or where disease risk is increasing over time, thus allowing public health interventions to be focused on these areas. Such aims are well suited to the statistical approach of clustering, and while much research has been done in this area in a purely spatial setting, only a handful of approaches have focused on spatiotemporal clustering of disease risk. Therefore, this paper outlines a new modeling approach for clustering spatiotemporal disease risk data, by clustering areas based on both their mean risk levels and the behavior of their temporal trends. The efficacy of the methodology is established by a simulation study, and is illustrated by a study of respiratory disease risk in Glasgow, Scotland.